Figure 3.
Predicted probability of various outcomes (AKI, AKR, and mortality at 30 days) as a function of baseline glucose levels in patients with preserved kidney function (eGFR > 60 mL/min/1.73 m2, n = 66,814), moderate renal dysfunction (60 > eGFR > 30 mL/min/1.73 m2, n = 20,822), and advanced renal failure (eGFR < 30 mL/min/1.73 m2, n = 8034). Lowest and highest 0.5% percentile of patients by glucose levels of each analyzed group were excluded. Data were plotted using cubic splines.